Manufacturer of Controlled Substances; Notice of Registration; Mallinckrodt LLC, 31391-31392 [2012-12817]
Download as PDF
<![CDATA[
31391
Federal Register / Vol. 77, No. 102 / Friday, May 25, 2012 / Notices
Drug
Schedule
5–Methoxy-N,N-diisopropyltryptamine (7439) .............................................................................................................................................
1-[1-(2–Thienyl)cyclohexyl]piperidine (7470) ...............................................................................................................................................
N–Benzylpiperazine (7493) .........................................................................................................................................................................
Heroin (9200) ...............................................................................................................................................................................................
Normorphine (9313) ....................................................................................................................................................................................
Amphetamine (1100) ...................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
Nabilone (7379) ...........................................................................................................................................................................................
1–Phenylcyclohexylamine (7460) ................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
Cocaine (9041) ............................................................................................................................................................................................
Codeine (9050) ............................................................................................................................................................................................
Diprenorphine (9058) ...................................................................................................................................................................................
Ecgonine (9180) ..........................................................................................................................................................................................
Levomethorphan (9210) ..............................................................................................................................................................................
Levorphanol (9220) .....................................................................................................................................................................................
Meperidine (9230) .......................................................................................................................................................................................
Metazocine (9240) .......................................................................................................................................................................................
Methadone (9250) .......................................................................................................................................................................................
Morphine (9300) ..........................................................................................................................................................................................
Thebaine (9333) ..........................................................................................................................................................................................
Levo-alphacetylmethadol (9648) .................................................................................................................................................................
Remifentanil (9739) .....................................................................................................................................................................................
Sufentanil (9740) .........................................................................................................................................................................................
Carfentanil (9743) ........................................................................................................................................................................................
Fentanyl (9801) ...........................................................................................................................................................................................
The company plans to manufacture
reference standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Sigma Aldrich Research Biochemicals,
Inc. to manufacture the listed basic
classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Sigma
Aldrich Research Biochemicals, Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: May 15, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–12821 Filed 5–24–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Mallinckrodt LLC
By Notice dated January 23, 2012, and
published in the Federal Register on
January 31, 2012, 77 FR 4828,
Mallinckrodt Inc., 3600 North Second
Street, St. Louis, Missouri 63147, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
mstockstill on DSK4VPTVN1PROD with NOTICES
Drug
Schedule
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
Codeine-N-oxide (9053) ..............................................................................................................................................................................
Dihydromorphine (9145) ..............................................................................................................................................................................
Difenoxin (9168) ..........................................................................................................................................................................................
Morphine-N-oxide (9307) .............................................................................................................................................................................
Normorphine (9313) ....................................................................................................................................................................................
Norlevorphanol (9634) .................................................................................................................................................................................
Amphetamine (1100) ...................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
Methylphenidate (1724) ...............................................................................................................................................................................
Nabilone (7379) ...........................................................................................................................................................................................
4–Anilino-N-phenethyl-4-piperidine (8333) ..................................................................................................................................................
Codeine (9050) ............................................................................................................................................................................................
Dihydrocodeine (9120) ................................................................................................................................................................................
Oxycodone (9143) .......................................................................................................................................................................................
Hydromorphone (9150) ...............................................................................................................................................................................
Diphenoxylate (9170) ..................................................................................................................................................................................
Ecgonine (9180) ..........................................................................................................................................................................................
Hydrocodone (9193) ....................................................................................................................................................................................
Levorphanol (9220) .....................................................................................................................................................................................
Meperidine (9230) .......................................................................................................................................................................................
Methadone (9250) .......................................................................................................................................................................................
Methadone intermediate (9254) ..................................................................................................................................................................
VerDate Mar<15>2010
17:55 May 24, 2012
Jkt 226001
PO 00000
Frm 00102
Fmt 4703
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Sfmt 4703
E:\FR\FM\25MYN1.SGM
25MYN1
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
31392
Federal Register / Vol. 77, No. 102 / Friday, May 25, 2012 / Notices
Drug
Schedule
Metopon (9260) ...........................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms)(9273) ...............................................................................................................................
Morphine (9300) ..........................................................................................................................................................................................
Oripavine (9330) ..........................................................................................................................................................................................
Thebaine (9333) ..........................................................................................................................................................................................
Opium tincture (9630) ..................................................................................................................................................................................
Opium, powdered (9639) .............................................................................................................................................................................
Oxymorphone (9652) ...................................................................................................................................................................................
Noroxymorphone (9668) ..............................................................................................................................................................................
Alfentanil (9737) ..........................................................................................................................................................................................
Remifentanil (9739) .....................................................................................................................................................................................
Sufentanil (9740) .........................................................................................................................................................................................
Fentanyl (9801) ...........................................................................................................................................................................................
The firm plans to manufacture the
listed controlled substances for internal
use and for sale to other companies.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Mallinckrodt, LLC., to manufacture the
listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Mallinckrodt, LLC., to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: May 15, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Record on Objection to Commission’s
Proposed Decision in Claim No. LIB–II–
083.
Status: Open.
All meetings are held at the Foreign
Claims Settlement Commission, 600 E
Street, NW., Washington, DC. Requests
for information, or advance notices of
intention to observe an open meeting,
may be directed to: Judith H. Lock,
Executive Officer, Foreign Claims
Settlement Commission, 600 E Street
NW., Suite 6002, Washington, DC
20579. Telephone: (202) 616–6975.
Jaleh F. Barrett,
Chief Counsel.
[FR Doc. 2012–12873 Filed 5–23–12; 11:15 am]
BILLING CODE 4410–BA–P
DEPARTMENT OF LABOR
Office of the Secretary
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Settlement
Agreements Between a Plan and Party
in Interest
ACTION:
Notice.
[FR Doc. 2012–12817 Filed 5–24–12; 8:45 am]
DEPARTMENT OF JUSTICE
Foreign Claims Settlement
Commission
[F.C.S.C. Meeting and Hearing Notice No.
05–12]
mstockstill on DSK4VPTVN1PROD with NOTICES
Sunshine Act Meeting
The Foreign Claims Settlement
Commission, pursuant to its regulations
(45 CFR 503.25) and the Government in
the Sunshine Act (5 U.S.C. 552b),
hereby gives notice in regard to the
scheduling of open meetings as follows:
Tuesday, June 5, 2012: 1 p.m.—
Issuance of Proposed Decisions in
claims against Libya; Hearing on the
VerDate Mar<15>2010
17:55 May 24, 2012
The Department of Labor
(DOL) is submitting the Employee
Benefits Security Administration
(EBSA) sponsored information
collection request (ICR) titled,
‘‘Settlement Agreements Between a Plan
and Party in Interest,’’ to the Office of
Management and Budget (OMB) for
review and approval for continued use
in accordance with the Paperwork
Reduction Act (PRA) of 1995 (44 U.S.C.
3501 et seq.).
DATES: Submit comments on or before
June 25, 2012.
ADDRESSES: A copy of this ICR with
applicable supporting documentation;
including a description of likely
respondents, proposed frequency of
response, and estimated total burden
may be obtained from the RegInfo.gov
SUMMARY:
BILLING CODE 4410–09–P
Jkt 226001
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
II
II
II
II
II
Web site, https://www.reginfo.gov/
public/do/PRAMain, on the day
following publication of this notice or
by contacting Michel Smyth by
telephone at 202–693–4129 (this is not
a toll-free number) or sending an email
to DOL_PRA_PUBLIC@dol.gov.
Submit comments about this request
to the Office of Information and
Regulatory Affairs, Attn: OMB Desk
Officer for DOL–EBSA, Office of
Management and Budget, New
Executive Office Building, Room 10235,
Washington, DC 20503, Telephone:
202–395–6929/Fax: 202–395–6881
(these are not toll-free numbers), email:
OIRA_submission@omb.eop.gov.
FOR FURTHER INFORMATION CONTACT:
Contact Michel Smyth by telephone at
202–693–4129 (this is not a toll-free
number) or by email at
DOL_PRA_PUBLIC@dol.gov.
SUPPLEMENTARY INFORMATION: Prohibited
Transaction Exemption (PTE) 94–71
exempts from certain restrictions of the
Employee Retirement Income Security
Act of 1974 (ERISA) and section
4975(c)(2) of the Internal Revenue Code
of 1986 (Code) a settlement agreement
entered into between a plan and a party
in interest resulting from an
investigation of an employee benefit
plan by the Department. PTE 03–39
similarly exempts from certain
restrictions of the ERISA and certain
taxes of the Code, settlement agreements
entered into between a plan and a party
in interest in avoidance of litigation.
This information collection is subject
to the PRA. A Federal agency generally
cannot conduct or sponsor a collection
of information, and the public is
generally not required to respond to an
information collection, unless it is
approved by the OMB under the PRA
and displays a currently valid OMB
Control Number. In addition,
notwithstanding any other provisions of
law, no person shall generally be subject
to penalty for failing to comply with a
collection of information if the
collection of information does not
E:\FR\FM\25MYN1.SGM
25MYN1
]]>Agencies
[Federal Register Volume 77, Number 102 (Friday, May 25, 2012)]
[Notices]
[Pages 31391-31392]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-12817]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
Mallinckrodt LLC
By Notice dated January 23, 2012, and published in the Federal
Register on January 31, 2012, 77 FR 4828, Mallinckrodt Inc., 3600 North
Second Street, St. Louis, Missouri 63147, made application by renewal
to the Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)..................... I
Codeine-N-oxide (9053)........................... I
Dihydromorphine (9145)........................... I
Difenoxin (9168)................................. I
Morphine-N-oxide (9307).......................... I
Normorphine (9313)............................... I
Norlevorphanol (9634)............................ I
Amphetamine (1100)............................... II
Methamphetamine (1105)........................... II
Methylphenidate (1724)........................... II
Nabilone (7379).................................. II
4-Anilino-N-phenethyl-4-piperidine (8333)........ II
Codeine (9050)................................... II
Dihydrocodeine (9120)............................ II
Oxycodone (9143)................................. II
Hydromorphone (9150)............................. II
Diphenoxylate (9170)............................. II
Ecgonine (9180).................................. II
Hydrocodone (9193)............................... II
Levorphanol (9220)............................... II
Meperidine (9230)................................ II
Methadone (9250)................................. II
Methadone intermediate (9254).................... II
[[Page 31392]]
Metopon (9260)................................... II
Dextropropoxyphene, bulk (non-dosage forms)(9273) II
Morphine (9300).................................. II
Oripavine (9330)................................. II
Thebaine (9333).................................. II
Opium tincture (9630)............................ II
Opium, powdered (9639)........................... II
Oxymorphone (9652)............................... II
Noroxymorphone (9668)............................ II
Alfentanil (9737)................................ II
Remifentanil (9739).............................. II
Sufentanil (9740)................................ II
Fentanyl (9801).................................. II
------------------------------------------------------------------------
The firm plans to manufacture the listed controlled substances for
internal use and for sale to other companies.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Mallinckrodt, LLC., to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Mallinckrodt, LLC., to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: May 15, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-12817 Filed 5-24-12; 8:45 am]
BILLING CODE 4410-09-P
